Loading…
CIK 0001799883 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("5am-venture-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARTIVA BIOTHERAPEUTICS INC | COM | $10.1M | 3.2%Prev: 2.5% | 2,353,304 SH | Increased |
| BIOHAVEN LTD | COM | $8.3M | 2.6%Prev: 2.6% | 738,972 SH | Increased+260,000 SH |
| CAMP4 THERAPEUTICS CORP | COM | $36.0M | 11.3%Prev: 6.4% | 5,869,091 SH | Increased |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $13.5M | 4.2%Prev: 4.7% | 497,270 SH | Increased |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $14.5M | 4.6%Prev: 6.0% | 580,945 SH | Decreased-100,000 SH |
| ENLIVEN THERAPEUTICS INC | COM | $11.9M | 3.7%Prev: 5.8% | 772,477 SH | Decreased |
| ENTRADA THERAPEUTICS INC | COM | $41.7M | 13.1%Prev: 9.0% | 4,056,379 SH | Increased-200,000 SH |
| ERASCA INC | COM | $20.1M | 6.3%Prev: 4.3% | 5,405,404 SH | Increased |
| EYEPOINT INC | COM NEW | $19.2M | 6.0% | 1,050,000 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $7.3M | 2.3%Prev: 3.0% | 572,665 SH | Decreased |
| MAPLIGHT THERAPEUTICS INC | COM | $16.7M | 5.2% | 950,011 SH | New |
| PHARVARIS N V | COM | $22.1M | 7.0%Prev: 7.3% | 797,600 SH | Increased |
| PROTARA THERAPEUTICS INC | COM STK | $7.3M | 2.3%Prev: 1.3% | 1,369,782 SH | Increased+569,782 SH |
| RALLYBIO CORP | COM | $2.5M | 0.8%Prev: 0.7% | 3,630,724 SH | Increased |
| SILENCE THERAPEUTICS PLC | ADS | $2.9M | 0.9%Prev: 0.9% | 476,200 SH | Increased |
| SKYE BIOSCIENCE INC | COM NEW | $7.3M | 2.3%Prev: 13.9% | 9,681,763 SH | Decreased |
| SURROZEN INC | COM NEW | $8.8M | 2.8%Prev: 1.5% | 387,500 SH | Increased+77,500 SH |
| TECTONIC THERAPEUTIC INC | COM | $12.7M | 4.0%Prev: 2.9% | 606,660 SH | Increased+95,000 SH |
| TYRA BIOSCIENCES INC | COM | $27.1M | 8.5%Prev: 4.8% | 1,029,298 SH | Increased+90,000 SH |
| VIRIDIAN THERAPEUTICS INC | COM | $22.9M | 7.2%Prev: 5.8% | 736,595 SH | Increased |
| ZENTALIS PHARMACEUTICALS INC | COM | $5.3M | 1.7%Prev: 0.3% | 3,947,913 SH | Increased+3,457,913 SH |
| 13F-HR |
| 0001799883-26-000003 |
| $287.9M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001085146-25-005241 | $260.1M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001799883-26-000002 | $360.2M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001085146-25-003293 | $264.4M | View |